SLXN
Biomotion Sciences Ordinary Shares
NASDAQ: SLXN · HEALTHCARE · BIOTECHNOLOGY
$0.61
-3.00% today
Updated 2026-04-30
Market cap
$2.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.96
Dividend yield
—
52W range
$0 – $22
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.00
+880.23%
12-Month target
$2,373.81
+387714.08%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.02M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-3.21M | $-4.94M | $-16.44M | $-11.91M | $-4.41M |
| EPS | — | — | — | — | $-8.96 |
| Free cash flow | $-3.38M | $-4.54M | $-8.42M | $-10.83M | $-3.02M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Biomotion Sciences Ordinary Shares trades at $0.61. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Biomotion Sciences Ordinary Shares's stock price?
Biomotion Sciences Ordinary Shares (SLXN) trades at $0.61.
Is Biomotion Sciences Ordinary Shares overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Biomotion Sciences Ordinary Shares (SLXN)?
The analyst target price is $6.00, representing +880.2% upside from the current price of $0.61.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-771.00%
Beta0.06
50D MA$1.35
200D MA$3.76
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—